MedTrace Logo

Circulating miRNA in Primary Hyperparathyroidism

NCT03931109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2024-08-01

No results posted yet for this study

Summary

The goal of this study is to: 1. Analyze the expression levels of circulating (serum) miRNAs in primary hyperparathyroidism patients with and without osteoporosis, and patients with osteoporosis undergoing thyroidectomy, and to correlate with clinical markers of bone remodeling including biochemical and radiologic studies. 2. To evaluate serum miRNA levels after treatment with parathyroidectomy.

Conditions

  • Primary Hyperparathyroidism
  • Osteoporosis, Postmenopausal

Sponsors & Collaborators

Principal Investigators

  • Heather Wachtel, MD · University of Pennsylvania Health System

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-07
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03931109 on ClinicalTrials.gov